Latest Asx Disclosures News

Page 7 of 8
333D Limited reported a 12% increase in quarterly cash receipts from digital asset management contracts, maintaining steady cash flow despite slight operating cash usage. The company’s annual contract revenue surpassed $970,000, reflecting growing traction in healthcare digital services.
Sophie Babbage
Sophie Babbage
28 July 2025
Raptis Group Limited has confirmed that director James Raptis will resign effective 30 September 2025, affirming the company’s compliance with ASX continuous disclosure rules.
Victor Sage
Victor Sage
23 July 2025
Kingsland Minerals has withdrawn its previously implied production target for the Leliyn Graphite Project’s processing plant, citing non-compliance with ASX disclosure rules and advising investors to disregard prior estimates.
Maxwell Dee
Maxwell Dee
22 July 2025
Biome Australia Limited has confirmed its record FY25 sales revenue of approximately $18.4 million, marking a 41% increase year-on-year, while affirming full compliance with ASX continuous disclosure rules.
Ada Torres
Ada Torres
9 July 2025
ENRG Elements Limited has confirmed the materiality of recent director resignations and appointments, clarifying timing and compliance with ASX disclosure rules.
Maxwell Dee
Maxwell Dee
20 June 2025
Cygnus Metals has clarified that its recent share price and volume spike stemmed from new assay results at its Golden Eye prospect and broader copper sector dynamics, confirming compliance with ASX disclosure rules.
Maxwell Dee
Maxwell Dee
10 June 2025
Locate Technologies has secured $1.45 million through a share placement and established a $2 million At-the-Market facility to boost financial flexibility, while unveiling a strategic plan to hold Bitcoin as part of its treasury management.
Sophie Babbage
Sophie Babbage
29 May 2025
Nufarm Limited confirms its half-year earnings align closely with analyst expectations despite a late-stage $16 million inventory valuation adjustment. The company maintains compliance with ASX disclosure rules amid market scrutiny.
Ada Torres
Ada Torres
26 May 2025
Heavy Minerals Limited attributes its recent share price jump to media coverage about its upcoming Port Gregory Pre-Feasibility Study and confirms compliance with ASX disclosure rules.
Maxwell Dee
Maxwell Dee
15 May 2025
Botanix Pharmaceuticals has clarified that recent share price movements are linked to a rumored US executive order on drug pricing, confirming no undisclosed material information. The company reassures investors of compliance with ASX disclosure rules amid market speculation.
Ada Torres
Ada Torres
12 May 2025
Mayne Pharma Group has acknowledged a delayed filing of a director's interest notice due to administrative oversight and is taking steps to reinforce compliance with ASX disclosure rules.
Ada Torres
Ada Torres
12 May 2025
Tivan Limited has responded to ASX inquiries about a social media post by its executive chair concerning fluorite exploration, affirming compliance with disclosure rules and pending assay results.
Maxwell Dee
Maxwell Dee
7 May 2025